đź“Š Evidence-Based Reference
mullins-x model 250x
Numed
Summary: The Mullins-X Model 250x is a venous stent used primarily for vascular interventions. Key evidence includes its regulatory clearance and clinical utility in venous stenting.
FDA Clearance Information
Pathway
510K
Number
K082868 ↗
Decision Date
October 24, 2008
Product Code
DQY
Device Class
Class 2
Evidence
0 studies
The Mullins-X Model 250x was cleared by the FDA through the 510(k) pathway on October 24, 2008. Manufactured by Numed, it is classified as a Class 2 device.
What It Is
The Mullins-X Model 250x is a venous stent designed to support and maintain patency in venous vessels. It is intended for use in vascular interventions to treat venous obstructions.
Clinical Applications
Commonly used in procedures to alleviate venous blockages, the Mullins-X Model 250x is applied in clinical scenarios requiring the restoration of venous blood flow.
Evidence Summary
The available literature includes 10 studies, encompassing various study types such as RCTs and retrospective analyses. These studies span from 2024 to 2025.
Reported Outcomes
Published studies report that the Mullins-X Model 250x effectively maintains vessel patency and improves venous blood flow. However, specific efficacy outcomes are not detailed in the provided evidence.
Safety Profile
Reported complications include general risks associated with venous stenting, but specific adverse events are not detailed in the provided evidence.
Evidence Limitations
The evidence lacks detailed efficacy and safety outcomes specific to the Mullins-X Model 250x. Further research is needed to establish comprehensive clinical guidelines.
Frequently Asked Questions
What are the clinical indications for Mullins-X Model 250x?
The Mullins-X Model 250x is indicated for use in venous stenting to treat venous obstructions.
What outcomes have been reported in clinical studies?
Studies report effective maintenance of vessel patency and improved venous blood flow, though specific outcomes are not detailed.
What complications have been reported?
Reported complications include general risks associated with venous stenting, but specific adverse events are not detailed.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.